UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000029590
Receipt No. R000033806
Scientific Title An accompanying research for the Phase II study of nivolumab + bevacizumab + paclitaxel in patients with HER2-negative metastatic breast cancer:WJOG9917B(WJOG9917BTR)
Date of disclosure of the study information 2017/10/17
Last modified on 2019/01/29 16:10:44

No. Disposal Last modified on Item of update
1 Insert 2017/10/17 11:15:46
2 Update 2017/10/18 12:56:08 Organization
Organization
Organization
Category of Funding Organization
3 Update 2017/12/04 10:11:09 Organization
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
4 Update 2017/12/04 10:12:25 Institutions
5 Update 2018/02/05 14:57:58 Recruitment status
6 Update 2019/01/29 16:10:44 Recruitment status


Contact us.